Havana sold seven million doses of its vaccines against him Covid-19 Sovereign 02 and Abdala to their ally of Nicaragua at a price of seven dollars a unitas revealed by an official document from Managua of the national plan for coverage and acquisition of vaccines, presented by the World Bank to access a loan of 116 million dollars.
According to local media Confidentialalthough the document did not indicate the total amount, this would have meant a disbursement of 49 million dollars for the Central American country.
This revelation is striking if one takes into account that the Cuban authorities supported their propaganda about the drugs developed on the Island in the promise of offering the developing world a cheap medicinewhich would be the solution to the hoarding of vaccines by rich countries.
Nevertheless, the price of seven dollars of the injectables on the Island is more than the cost of the dose of the Oxford/AstraZeneca vaccine ($5.50) and almost the same as what the Russian Sputnik V and Johnson & Johnson are worth, both at almost eight dollars.
Moderna’s one-dose US vaccine is the most expensive among the most widely used in the world ($32), while China’s Coronavac has a price per dose of $24 and Pfizer’s just over $16.
Outside of sales to allies such as Venezuela, Vietnam, Iran or Saint Vincent and the Grenadines, in addition to Nicaragua and Mexico, as well as a donation to Syria, Havana has not obtained the mandatory approval of the World Health Organization (WHO) to enter the global vaccine market.
Until May 26, date of publication the most recent update of the drug evaluation procedure by the international entity, Abdala had scheduled the delivery of their documentation during June, while Soberana 01, Soberana 02 and Soberana Plus did not have an approved schedule for their consideration.
The Managua report reveals that Daniel Ortega’s regime paid Russia five and a half dollars for each unit of Sputnik V, while Sputnik Light cost $12.90 per dose. From the first he acquired 546,000 doses and from the second 3,686,315.
This meant a total expenditure between February 2021 and January 2022 of 101.9 million dollars for Managuawhich also purchased 1,252,800 doses from AstraZeneca for $6,890,000 through the COVAX mechanism.
Until January 2022, Nicaragua has had 19.8 million doses of different types of anti-Covid injectables, including Covishield, AstraZeneca, Sputnik V and Light, Soberana 02, Abdala, Janssen, Pfizer and Sinopharm. 62.82% of these correspond to purchases and the remaining 37.1% to donations.
–
